Ngā hua rapu - Barry Antonacci

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against <i>Aspergillus</i> and <i>Candida</i>

    In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against <i>Aspergillus</i> and <i>Candida</i> mā Anthony Cacciapuoti, David Loebenberg, Erik Corcoran, Fred Menzel, E. L. Moss, Christine Norris, Monika Michalski, Kimberly Raynor, Judith Halpern, Cara Mendrick, Brian M. Arnold, Barry Antonacci, Raulo Parmegiani, T. Yarosh-Tomaine, George H. Miller, R S Hare

    I whakaputaina 2000
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Discovery of a Novel Class of Orally Active Antifungal β-1,3- <scp>d</scp> -Glucan Synthase Inhibitors

    Discovery of a Novel Class of Orally Active Antifungal β-1,3- <scp>d</scp> -Glucan Synthase Inhibitors mā Scott S. Walker, Yiming Xu, Ilias Triantafyllou, Michelle F. Waldman, Cara Mendrick, Nathaniel H. Brown, Paul A. Mann, Andrew S. Chau, Reena Patel, Nicholas P. Bauman, Christine Norris, Barry Antonacci, Maya Gurnani, Anthony Cacciapuoti, Paul M. McNicholas, Samuel B. Wainhaus, R. Jason Herr, Rongze Kuang, Robert Aslanian, Pauline C. Ting, Todd A. Black

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: